Moxetumomab Pasudotox-tdfk and Pediazole
Determining the interaction of Moxetumomab Pasudotox-tdfk and Pediazole and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: erythromycin / sulfisoxazole
Brand name:
Synonyms: Pediazole (Oral)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab Pasudotox-tdfk-Pediotic
- Moxetumomab Pasudotox-tdfk-Pediox
- Moxetumomab Pasudotox-tdfk-Peditrace
- Moxetumomab Pasudotox-tdfk-PedvaxHIB
- Moxetumomab Pasudotox-tdfk-Peg Intron RP
- Moxetumomab Pasudotox-tdfk-PEG-3350 with Electolytes
- Pediazole-Moxetumomab pasudotox-tdfk Intravenous
- Pediazole-Moxifloxacin
- Pediazole-Moxifloxacin (Systemic)
- Pediazole-Moxifloxacin Hydrochloride
- Pediazole-Moxifloxacin Injection
- Pediazole-Moxifloxacin Intravenous